Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Total 13F shares
-
203,269,695
-
Share change
-
-1,682,640
-
Total reported value
-
$185,470,444
-
Put/Call ratio
-
161%
-
Price per share
-
$0.91
-
Number of holders
-
95
-
Value change
-
+$158,999
-
Number of buys
-
52
-
Number of sells
-
37
Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2023
As of 31 Dec 2023,
Gossamer Bio, Inc. - Common Stock (GOSS) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
203,269,695 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, Artal Group S.A., VANGUARD GROUP INC, EcoR1 Capital, LLC, Octagon Capital Advisors LP, ARCH Venture Management, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, Eversept Partners, LP, and CITADEL ADVISORS LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.